RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Aug 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-08-14

Reporting Person: Cabatuan Nelson (Principal Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-14	Employee Stock Option (Right to Buy)	$2.76	A	20000	Acquired	2028-08-14	Common Stock (20000)	Direct

Footnotes

F1: The shares of common stock subject to the option vest in equal monthly installments over forty-eight (48) months from the vesting commencement date of August 14, 2018.